BFB Health Limited (HKG:0205)
Hong Kong · Delayed Price · Currency is HKD 0.8400
0.00 (0.00%)
At close: Feb 13, 2026
BFB Health Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 30.56 | 30.15 | 38.38 | 73.16 | 68.35 | 80.17 | |
Revenue Growth (YoY) | -4.13% | -21.44% | -47.54% | 7.04% | -14.74% | -8.09% |
Cost of Revenue | 20.94 | 17.74 | 27.15 | 31.92 | 26.69 | 23.99 |
Gross Profit | 9.63 | 12.42 | 11.23 | 41.24 | 41.66 | 56.17 |
Selling, General & Admin | 25.31 | 24.79 | 47.89 | 25.14 | 28.95 | 50.72 |
Operating Expenses | 50.49 | 49.97 | 45.7 | 25.14 | 28.95 | 50.72 |
Operating Income | -40.86 | -37.55 | -34.47 | 16.1 | 12.71 | 5.46 |
Interest Expense | -1.09 | -1.92 | -1.86 | -1.68 | -2.3 | -2.32 |
Interest & Investment Income | 0.08 | 0.08 | 0.45 | 0.2 | 0.01 | 0.09 |
Earnings From Equity Investments | -15.42 | -22.53 | -5.27 | -2.71 | -11.59 | -16.34 |
Currency Exchange Gain (Loss) | -1.36 | 2.12 | 2.69 | 16.15 | -7.18 | -9.68 |
Other Non Operating Income (Expenses) | -6.51 | -6.85 | -6.15 | 2.47 | 1.47 | 5.16 |
EBT Excluding Unusual Items | -65.17 | -66.65 | -44.61 | 30.53 | -6.87 | -17.63 |
Impairment of Goodwill | - | - | - | - | - | -12.27 |
Gain (Loss) on Sale of Investments | 53.73 | 9.91 | 12.12 | -118.04 | -36.67 | -82.94 |
Gain (Loss) on Sale of Assets | -12.85 | 7.12 | 17.57 | -0.1 | - | 0.45 |
Asset Writedown | -9.53 | -9.53 | - | - | - | -34.06 |
Other Unusual Items | 29.74 | 29.74 | -25.55 | 0.32 | - | 0.53 |
Pretax Income | -4.08 | -29.4 | -40.47 | -87.29 | -43.54 | -145.9 |
Income Tax Expense | -0.52 | -0.52 | -3.07 | 1.97 | 1.05 | -2.51 |
Earnings From Continuing Operations | -3.56 | -28.88 | -37.4 | -89.26 | -44.59 | -143.39 |
Minority Interest in Earnings | -6.7 | -5.71 | 14.12 | 6.79 | 4.46 | 5.56 |
Net Income | -10.26 | -34.6 | -23.28 | -82.47 | -40.14 | -137.83 |
Net Income to Common | -10.26 | -34.6 | -23.28 | -82.47 | -40.14 | -137.83 |
Shares Outstanding (Basic) | 736 | 736 | 736 | 656 | 511 | 348 |
Shares Outstanding (Diluted) | 736 | 736 | 736 | 656 | 511 | 348 |
Shares Change (YoY) | -5.46% | - | 12.23% | 28.26% | 46.81% | 9.31% |
EPS (Basic) | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 | -0.40 |
EPS (Diluted) | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 | -0.40 |
Free Cash Flow | 14.32 | 22.95 | -36.8 | -7.83 | -22.85 | -24.21 |
Free Cash Flow Per Share | 0.02 | 0.03 | -0.05 | -0.01 | -0.04 | -0.07 |
Gross Margin | 31.49% | 41.18% | 29.26% | 56.37% | 60.95% | 70.07% |
Operating Margin | -133.70% | -124.55% | -89.82% | 22.01% | 18.59% | 6.80% |
Profit Margin | -33.56% | -114.74% | -60.66% | -112.73% | -58.72% | -171.93% |
Free Cash Flow Margin | 46.85% | 76.13% | -95.89% | -10.70% | -33.43% | -30.20% |
EBITDA | -40.56 | -37.25 | -34.21 | 16.54 | 13.58 | 16.21 |
EBITDA Margin | -132.71% | -123.54% | -89.14% | 22.61% | 19.86% | 20.23% |
D&A For EBITDA | 0.3 | 0.3 | 0.26 | 0.44 | 0.87 | 10.76 |
EBIT | -40.86 | -37.55 | -34.47 | 16.1 | 12.71 | 5.46 |
EBIT Margin | -133.70% | -124.55% | -89.82% | 22.01% | 18.59% | 6.80% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.